|
1
|
Chen W, He Y, Zheng R, Zhang S, Zeng H,
Zou X and He J: Esophageal cancer incidence and mortality in China,
2009. J Thorac Dis. 5:19–26. 2013.PubMed/NCBI
|
|
2
|
Cook MB, Chow WH and Devesa SS:
Oesophageal cancer incidence in the United States by race, sex, and
histologic type, 1977–2005. Br J Cancer. 101:855–859. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu XC: Risk factors and gene expression in
esophageal cancer. Methods Mol Biol. 471:335–360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paulson TG and Reid BJ: Focus on Barrett's
esophagus and esophageal adenocarcinoma. Cancer Cell. 6:11–16.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Besnard V, Wert SE, Hull WM and Whitsett
JA: Immunohistochemical localization of Foxa1 and Foxa2 in mouse
embryos and adult tissues. Gene Expr Patterns. 5:193–208. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaestner KH, Hiemisch H, Luckow B and
Schütz G: The HNF-3 gene family of transcription factors in mice:
Gene structure, cDNA sequence, and mRNA distribution. Genomics.
20:377–385. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaestner KH: The making of the liver:
Developmental competence in foregut endoderm and induction of the
hepatogenic program. Cell Cycle. 4:1146–1148. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zaret K: Developmental competence of the
gut endoderm: Genetic potentiation by GATA and HNF3/fork head
proteins. Dev Biol. 209:1–10. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Augello MA, Hickey TE and Knudsen KE:
FOXA1: Master of steroid receptor function in cancer. EMBO J.
30:3885–3894. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao N, Le Lay J, Qin W, Doliba N, Schug J,
Fox AJ, Smirnova O, Matschinsky FM and Kaestner KH: Foxa1 and Foxa2
maintain the metabolic and secretory features of the mature
beta-cell. Mol Endocrinol. 24:1594–1604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferri AL, Lin W, Mavromatakis YE, Wang JC,
Sasaki H, Whitsett JA and Ang SL: Foxa1 and Foxa2 regulate multiple
phases of midbrain dopaminergic neuron development in a
dosage-dependent manner. Development. 134:2761–2769. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mavromatakis YE, Lin W, Metzakopian E,
Ferri AL, Yan CH, Sasaki H, Whisett J and Ang SL: Foxa1 and Foxa2
positively and negatively regulate Shh signalling to specify
ventral midbrain progenitor identity. Mech Dev. 128:90–103. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carroll JS, Liu XS, Brodsky AS, Li W,
Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger
TR, et al: Chromosome-wide mapping of estrogen receptor binding
reveals long-range regulation requiring the forkhead protein FoxA1.
Cell. 122:33–43. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao N, White P and Kaestner KH:
Establishment of intestinal identity and epithelial-mesenchymal
signaling by Cdx2. Dev Cell. 16:588–599. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Slack JM: Metaplasia and
transdifferentiation: From pure biology to the clinic. Nat Rev Mol
Cell Biol. 8:369–378. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Robbins CM, Tembe WA, Baker A, Sinari S,
Moses TY, Beckstrom-Sternberg S, Beckstrom-Sternberg J, Barrett M,
Long J, Chinnaiyan A, et al: Copy number and targeted mutational
analysis reveals novel somatic events in metastatic prostate
tumors. Genome Res. 21:47–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jain RK, Mehta RJ, Nakshatri H, Idrees MT
and Badve SS: High-level expression of forkhead-box protein A1 in
metastatic prostate cancer. Histopathology. 58:766–772. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salem M, O'Brien JA, Bernaudo S, Shawer H,
Ye G, Brkić J, Amleh A, Vanderhyden BC, Refky B, Yang BB, et al:
miRNA-590-3p promotes ovarian cancer growth and metastasis via a
novel FOXA2-versican pathway. Cancer Res. 78:4175–4190. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang B, Liu G, Ding L, Zhao J and Lu Y:
FOXA2 promotes the proliferation, migration and invasion, and
epithelial mesenchymal transition in colon cancer. Exp Ther Med.
16:133–140. 2018.PubMed/NCBI
|
|
21
|
Watts JA, Zhang C, Klein-Szanto AJ,
Kormish JD, Fu J, Zhang MQ and Zaret KS: Study of FoxA pioneer
factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a
potential indicator of esophageal adenocarcinoma development. PLoS
Genet. 7:e10022772011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin L, Miller CT, Contreras JI, Prescott
MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, et
al: The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1),
on chromosome band 14q13 is amplified and overexpressed in
esophageal and lung adenocarcinomas. Cancer Res. 62:5273–5279.
2002.PubMed/NCBI
|
|
23
|
Sano M, Aoyagi K, Takahashi H, Kawamura T,
Mabuchi T, Igaki H, Tachimori Y, Kato H, Ochiai A, Honda H, et al:
Forkhead box A1 transcriptional pathway in KRT7-expressing
esophageal squamous cell carcinomas with extensive lymph node
metastasis. Int J Oncol. 36:321–330. 2010.PubMed/NCBI
|
|
24
|
Wang DH, Tiwari A, Kim ME, Clemons NJ,
Regmi NL, Hodges WA, Berman DM, Montgomery EA, Watkins DN, Zhang X,
et al: Hedgehog signaling regulates FOXA2 in esophageal
embryogenesis and Barrett's metaplasia. J Clin Invest.
124:3767–3780. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Edge SB, Byrd DR, Compton CC, et al: AJCC
Cancer Staging Manual. (7th). (New York). Springer. 2010.
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hao Y, Triadafilopoulos G, Sahbaie P,
Young HS, Omary MB and Lowe AW: Gene expression profiling reveals
stromal genes expressed in common between Barrett's esophagus and
adenocarcinoma. Gastroenterology. 131:925–933. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim SM, Park YY, Park ES, Cho JY, Izzo JG,
Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, et al: Prognostic
biomarkers for esophageal adenocarcinoma identified by analysis of
tumor transcriptome. PLoS One. 5:e150742010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang S, Zhan M, Yin J, Abraham JM, Mori Y,
Sato F, Xu Y, Olaru A, Berki AT, Li H, et al: Transcriptional
profiling suggests that Barrett's metaplasia is an early
intermediate stage in esophageal adenocarcinogenesis. Oncogene.
25:3346–3356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu YP, Ma L, Wang SJ, Chen YN, Wu GX, Han
M and Wang XL: Prognostic value of lymph node metastases and lymph
node ratio in esophageal squamous cell carcinoma. Eur J Surg Oncol.
36:155–159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yazbeck R, Jaenisch SE and Watson DI: From
blood to breath: New horizons for esophageal cancer biomarkers.
World J Gastroenterol. 22:10077–10083. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duncan SA, Navas MA, Dufort D, Rossant J
and Stoffel M: Regulation of a transcription factor network
required for differentiation and metabolism. Science. 281:692–695.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kalkuhl A, Kaestner K, Buchmann A and
Schwarz M: Expression of hepatocyte-enriched nuclear transcription
factors in mouse liver tumours. Carcinogenesis. 17:609–612. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen G, Korfhagen TR, Karp CL, Impey S, Xu
Y, Randell SH, Kitzmiller J, Maeda Y, Haitchi HM, Sridharan A, et
al: Foxa3 induces goblet cell metaplasia and inhibits innate
antiviral immunity. Am J Respir Crit Care Med. 189:301–313. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park SW, Verhaeghe C, Nguyenvu LT, Barbeau
R, Eisley CJ, Nakagami Y, Huang X, Woodruff PG, Fahy JV and Erle
DJ: Distinct roles of FOXA2 and FOXA3 in allergic airway disease
and asthma. Am J Respir Crit Care Med. 180:603–610. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma X, Xu L, Gavrilova O and Mueller E:
Role of forkhead box protein A3 in age-associated metabolic
decline. Proc Natl Acad Sci USA. 111:14289–14294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shen W, Scearce LM, Brestelli JE, Sund NJ
and Kaestner KH: Foxa3 (hepatocyte nuclear factor 3gamma) is
required for the regulation of hepatic GLUT2 expression and the
maintenance of glucose homeostasis during a prolonged fast. J Biol
Chem. 276:42812–42817. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ang SL, Wierda A, Wong D, Stevens KA,
Cascio S, Rossant J and Zaret KS: The formation and maintenance of
the definitive endoderm lineage in the mouse: involvement of
HNF3/forkhead proteins. Development. 119:1301–1315. 1993.PubMed/NCBI
|
|
40
|
Monaghan AP, Kaestner KH, Grau E and
Schütz G: Postimplantation expression patterns indicate a role for
the mouse forkhead/HNF-3 alpha, beta and gamma genes in
determination of the definitive endoderm, chordamesoderm and
neuroectoderm. Development. 119:567–578. 1993.PubMed/NCBI
|
